University of Oxford - Nuffield Department of Medicine, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, University of Cambridge - Department of Genetics, University of Oxford, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford - Nuffield Department of Medicine, European Bioinformatics Institute (EMBL-EBI), University of Oxford - Nuffield Department of Medicine, Imperial College London, Harvard University - Harvard Medical School, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, University of Oxford, Nuffield Department of Medicine, John Radcliffe Hospital, Foundation for Innovative New Diagnostics (FIND), Foundation for Innovative New Diagnostics (FIND), Foundation for Innovative New Diagnostics (FIND), Foundation for Innovative New Diagnostics (FIND), World Health Organization (WHO) - Global Tuberculosis Programme, World Health Organization (WHO) - Global Tuberculosis Programme, University of Oxford - Nuffield Department of Medicine, Independent, Independent, University of Oxford - Nuffield Department of Medicine, World Health Organization (WHO) - Global Tuberculosis Programme and University of California, San Diego (UCSD)